Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV–Primed Children in the Philippines

We assessed antibody persistence following booster vaccination with a Japanese encephalitis chimeric virus vaccine (JE-CV; IMOJEV) in JE-CV–primed children. In an open phase 3 trial, 349 children in the Philippines, who received JE-CV 2 years previously, received a booster dose. JE neutralizing anti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Infect Dis
Autores principales: Capeding, Maria Rosario, Alberto, Edison R, Bouckenooghe, Alain, Laot, Thelma M, Chansinghakul, Danaya, Monfredo, Céline, Machabert, Tifany, Feroldi, Emmanuel
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2018
Materias:
Major Articles and Brief Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5853961/
https://ncbi.nlm.nih.gov/pubmed/29325161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jix601
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares